Accordingly, AKT1 maintains cytoplasmic SLC9A6‐126aa in a T77‐dependent manner, whereas AKT1 deficiency in NAFLD exacerbates lipid dysregulation by increasing the nuclear import of SLC9A6‐126aa. The gene discussed is SLC9A6; the disease is metabolic dysfunction-associated steatotic liver disease.